| dc.contributor.author | Ndinya-Achola Jeckoniah O. | |
| dc.contributor.author | Nsanze, H | |
| dc.contributor.author | Karasira, P | |
| dc.contributor.author | Fransen, L | |
| dc.contributor.author | D'Costa, LJ | |
| dc.contributor.author | Piot, P | |
| dc.contributor.author | Ronald, AR | |
| dc.date.accessioned | 2013-04-26T12:45:58Z | |
| dc.date.available | 2013-04-26T12:45:58Z | |
| dc.date.issued | 1986 | |
| dc.identifier.citation | Genitourin Med. 1986 Jun;62(3):202-4 | en |
| dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/3733082 | |
| dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/17157 | |
| dc.description.abstract | Amoxycillin and clavulanic acid (Augmentin; Beecham Research Laboratories) was used to treat patients with bacteriologically proved chancroid in three different dose regimens. A single dose of Augmentin (amoxycillin 3 g, clavulanic acid 350 mg) was found to be ineffective. A similar dose repeated after 24 hours was equally ineffective, but a dose (amoxycillin 500 mg, clavulanic acid 250 mg) given every 8 hours for three days was found to be effective. The drug was well tolerated and no side effects were noted in any of the patients treated | en |
| dc.language.iso | en | en |
| dc.title | Three day oral course of Augmentin to treat chancroid. | en |
| dc.type | Article | en |
| local.publisher | Department of Medical Microbiology, University of Nairobi, Kenya | en |
